Houlihan Financial Resource Group, Ltd. Gritstone Bio, Inc. Transaction History
Houlihan Financial Resource Group, Ltd.
- $223 Million
- Q1 2024
A detailed history of Houlihan Financial Resource Group, Ltd. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Houlihan Financial Resource Group, Ltd. holds 20,000 shares of GRTS stock, worth $11,399. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$11,399
Previous $41,000
24.39%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding GRTS
# of Institutions
98Shares Held
45.6MCall Options Held
861KPut Options Held
4.52M-
Morgan Stanley New York, NY6.74MShares$3.84 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.79MShares$3.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.76MShares$3.28 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$2.7 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA3.56MShares$2.03 Million12.76% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $41.6M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...